These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 10562759)

  • 41. Should indirect costs and benefits be included?
    Henry DA
    Pharmacoeconomics; 1992 Jun; 1(6):462. PubMed ID: 10147025
    [No Abstract]   [Full Text] [Related]  

  • 42. Letter: East-West differences in the economic impact of functional dyspepsia.
    Mahadeva S; Goh KL
    Aliment Pharmacol Ther; 2013 Sep; 38(6):655. PubMed ID: 23964735
    [No Abstract]   [Full Text] [Related]  

  • 43. Letter: East-West differences in the economic impact of functional dyspepsia--authors' reply.
    Lacy BE; Crowell MD; Talley NJ
    Aliment Pharmacol Ther; 2013 Sep; 38(6):656. PubMed ID: 23964736
    [No Abstract]   [Full Text] [Related]  

  • 44. The effect of a Helicobacter pylori treatment strategy on health care expenditures in patients with peptic ulcer disease and dyspepsia.
    Kearney DJ; Liu CF; Crump C; Brousal A
    Am J Gastroenterol; 2003 Sep; 98(9):1952-62. PubMed ID: 14499771
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Population-based and opportunistic screening and eradication of Helicobacter pylori. An analysis using trial baseline data. Leeds H. pylori Study Group.
    Mason JM; Moayyedi P; Young PJ; Duffett S; Crocombe W; Drummond MF; Axon AT
    Int J Technol Assess Health Care; 1999; 15(4):649-60. PubMed ID: 10645106
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Eradicating Helicobacter pylori in non-ulcer dyspepsia may not be cost effective.
    Formoso G; Maestri E; Magrini N; Koch M; Capurso L; Liberati A
    BMJ; 2001 Mar; 322(7285):557. PubMed ID: 11263460
    [No Abstract]   [Full Text] [Related]  

  • 47. The National Sentinel Audit Project on the management of dyspepsia and H. pylori.
    Farrington M; Masterman A
    Br J Gen Pract; 1999 Jun; 49(443):488. PubMed ID: 10562759
    [No Abstract]   [Full Text] [Related]  

  • 48. [Should Helicobacter pylori be eradicated in patients with functional dyspepsia?].
    Elizalde I; Borda F
    Gastroenterol Hepatol; 2000 Feb; 23 Suppl 2():43-6. PubMed ID: 11968334
    [No Abstract]   [Full Text] [Related]  

  • 49. [Should Helicobacter pylori infection be considered in the management of dyspeptic patients?].
    De Korwin JD
    Gastroenterol Clin Biol; 1999 Oct; 23(10 Pt 2):C79-94. PubMed ID: 10880917
    [No Abstract]   [Full Text] [Related]  

  • 50. The health economics of Helicobacter pylori infection.
    Moayyedi P
    Best Pract Res Clin Gastroenterol; 2007; 21(2):347-61. PubMed ID: 17382282
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Symptomatic treatment and H. pylori eradication therapy for nonulcer dyspepsia.
    Smucny J
    Am Fam Physician; 2001 Nov; 64(9):1605-8. PubMed ID: 11730316
    [No Abstract]   [Full Text] [Related]  

  • 52.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.